Literature DB >> 7257744

Further studies of the chemical sensitivity of the oscillatory potentials of the electroretinogram (ERG). II. Glutamate-aspartate-and dopamine antagonists.

L Wachtmeister.   

Abstract

The effects on the oscillatory potentials (OPs) of the ERG of some pharmacological agents, which antagonize the putative neurotransmitters glutamate aspartate and dopamine were tested. GDEE and alpha-aminoadipate, blocking agents of the excitatory amino acids glutamate and aspartate, respectively, decreased the amplitude of all the OPs. The amplitude of the b-wave was simultaneously reduced. Thus, no selective or differential sensitivity of the OPs was found, which suggests that glutamate- or aspartate-sensitive neuronal pathways do not seem to be directly involved in the generation of the OPs. Haloperidol, which antagonizes the effect of the inhibitory transmitter agent dopamine, differentially affected the OPs. The earlier OPs appeared more sensitive to low doses of the drug than the later ones. Such doses only slightly decreased the maximum amplitude of the b-wave and did not affect the a-wave. Thus, these findings indicate and support previous suggestions that the individual oscillatory peaks are likely to have different origins and that only inhibitory feed-back synapses give rise to the OPs.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7257744     DOI: 10.1111/j.1755-3768.1981.tb02987.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  24 in total

1.  Extraction and modelling of oscillatory potentials.

Authors:  Bang Viet Bui; James Andrew Armitage; Algis Jonas Vingrys
Journal:  Doc Ophthalmol       Date:  2002-01       Impact factor: 2.379

2.  Dopamine D2 receptors preferentially regulate the development of light responses of the inner retina.

Authors:  Ning Tian; Hong-ping Xu; Ping Wang
Journal:  Eur J Neurosci       Date:  2014-11-13       Impact factor: 3.386

3.  Alteration of electroretinographic recordings when performed under sedation or halogenate anesthesia in a pediatric population.

Authors:  François Tremblay; Joan E Parkinson
Journal:  Doc Ophthalmol       Date:  2003-11       Impact factor: 2.379

4.  The effect of 2-amino-4-phosphonobutyric acid on the oscillatory potentials of the electroretinogram.

Authors:  P Guité; P Lachapelle
Journal:  Doc Ophthalmol       Date:  1990-09       Impact factor: 2.379

5.  Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia.

Authors:  Massimo Dal Monte; Valentina Latina; Elena Cupisti; Paola Bagnoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-07       Impact factor: 3.000

6.  Dose-dependency and time-course of electrophysiologic short-term effects of VIAGRA: a case study.

Authors:  Herbert Jägle; Christine Jägle; Ludwig Sèrey; Lindsay T Sharpe
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

7.  The effect of iodoacetic acid on the electroretinogram and oscillatory potentials in rabbits.

Authors:  P Lachapelle; J Benoit; P Guité; C N Tran; S Molotchnikoff
Journal:  Doc Ophthalmol       Date:  1990-08       Impact factor: 2.379

8.  The influence of adaptation on the oscillatory potentials of the human electroretinogram.

Authors:  X X Li; N Yuan; J Hong; P Song
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

9.  Effects of alpha-aminoadipic acid on the glutamate-isolated P III of the rabbit electroretinogram.

Authors:  A Reichenbach; F Wohlrab
Journal:  Doc Ophthalmol       Date:  1985-06-30       Impact factor: 2.379

10.  Attenuation of oscillatory potentials in nob2 mice.

Authors:  Minzhong Yu; Neal S Peachey
Journal:  Doc Ophthalmol       Date:  2007-05-04       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.